Defibrotide (DF) for the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post SCT: Final results of a phase II, multicenter, randomized study and preliminary analyses of surrogate markers and ultrasound findings


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Richardson, PG; Soiffer, RJ; Antin, JH; Voss, SD; Jin, Z; Kurtzberg, J; Martin, PL; Hockenbery, D; Murray, KF; Vogelsang, GB; Chen, A; Krishnan, A; Kernan, NA; Avigan, D; Spitzer, TR; Iannone, R; Giralt, S; Warren, D; Momtaz, P; Bradwin, G; Iacobelli, M; McDonald, GB; Guinan, EC

Published Date

  • November 16, 2004

Published In

Volume / Issue

  • 104 / 11

Start / End Page

  • 103A - 104A

Published By


  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 46th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • San Diego, CA

Conference Start Date

  • December 4, 2004

Conference End Date

  • December 7, 2004